How many studies have been conducted on Adenomatous Polyposis Coli Protein?

BiohacksAI has indexed 128 PubMed studies on Adenomatous Polyposis Coli Protein. 10% of studies involve human subjects.

What are the main research areas for Adenomatous Polyposis Coli Protein?

The primary research domains for Adenomatous Polyposis Coli Protein are 🔬 Oncology, 🦴 Bone & Joint, 🦠 Gut & Microbiome. This is based on analysis of 128 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Adenomatous Polyposis Coli Protein

A negative regulator of beta-catenin signaling which is mutant in ADENOMATOUS POLYPOSIS COLI and GARDNER SYNDROME.

128+ PubMed studies analyzed · Evidence Score: 44.8

Research Domains

Adenomatous Polyposis Coli Protein has been studied across 14 research domains including 🔬 Oncology, 🦴 Bone & Joint, 🦠 Gut & Microbiome, 🫁 Liver & Detox, 🧠 Memory. The primary research focus is 🔬 Oncology with 48% of studies addressing this area.

Loading evidence profile...

This evidence profile for Adenomatous Polyposis Coli Protein is generated deterministically from 128 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.